LONG COVID-19

Clinical trials for LONG COVID-19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID-19 trials appear

Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 5 Completed 7

New drug trial targets lingering COVID symptoms

Disease control Recruiting now

This study is testing whether a drug called Anktiva is safe for people with Long COVID—persistent symptoms that continue after the initial infection has cleared. The trial will enroll 40 adults who have had bothersome Long COVID symptoms for at least 60 days. Researchers will clo…

Matched conditions: LONG COVID-19

Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

LONG COVID-19

Get alerted when new LONG COVID-19 trials appear

New drug trial targets lingering COVID symptoms